How did Biofrontera's revenue and expenses trend in Q4 2024 compared to previous quarters?

Biofrontera's revenue and expenses in Q4 2024 showed a general upward trend compared to the previous quarters, with a slight dip in revenue growth in Q1 2024.

1. **Revenue Trend**: The total revenue for Q4 2024 was $37.32 million, which is an increase from the previous quarter's revenue of $24.76 million in Q3 2024. This indicates a positive trend in revenue generation, with the highest revenue recorded in Q4 2024 among the quarters provided.
2. **Expense Trend**: The total expenses for Q4 2024 were $7.91 million, which is the highest among all quarters. The expenses in Q3 2024 were $15.75 million, and in Q2 2024, they were $24.76 million. This suggests that Q4 2024 had the highest expenses among the four quarters.

3. **Growth Rate**: Biofrontera experienced a slight dip in revenue growth rate from Q3 to Q4, with a year-over-year growth rate of 0.1% in Q4 2024 compared to Q3 2024. However, the overall trend shows a positive growth in revenue and expenses over the year.

|code|Ticker|Name|Date|Total Revenue (FY) YoY|Total Expenses (FY) YoY|market_code|
|---|---|---|---|---|---|---|
|BFRI|BFRI.O|Biofrontera|2023|18.821929273906676||186|
|BFRI|BFRI.O|Biofrontera|2024|9.538904053300461||186|